Outcome-Driven Cluster Analysis with Application to Microarray Data

por Hsu, Jessie J., Finkelstein, Dianne M., Schoenfeld, David A.
Publicado 2015

Varied Clinical Ketogenic Diets Elicit Both Shared and Unique Functional and Taxonomic Responses on the Human Gut Microbiome in Refractory Epilepsy

por Özcan, Ezgi, Yu, Kristie, Arino, Mariana, Hsu, Jessie, Dinh, Lyna, Lum, Gregory, Hsiao, Elaine
Publicado 2022

Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells

por von Levetzow, Cornelia, Jiang, Xiaohua, Gwye, Ynnez, von Levetzow, Gregor, Hung, Long, Cooper, Aaron, Hsu, Jessie Hao-Ru, Lawlor, Elizabeth R.
Publicado 2011

Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program

por Morley, Roland, Cardenas, Alison, Hawkins, Peter, Suzuki, Yasuyo, Paton, Virginia, Phan, See-Chun, Merchant, Mark, Hsu, Jessie, Yu, Wei, Xia, Qi, Koralek, Daniel, Luhn, Patricia, Aldairy, Wassim
Publicado 2015

Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study

por de la Cruz-Merino, Luis, Di Guardo, Lorenza, Grob, Jean-Jacques, Venosa, Alfredo, Larkin, James, McArthur, Grant A., Ribas, Antoni, Ascierto, Paolo A., Evans, Jeffrey T. R., Gomez-Escobar, Antonio, Barteselli, Giulio, Eng, Susan, Hsu, Jessie J., Uyei, Anne, Dréno, Brigitte
Publicado 2017

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF(V600) Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

por Ascierto, Paolo A., Dréno, Brigitte, Larkin, James, Ribas, Antoni, Liszkay, Gabriella, Maio, Michele, Mandalà, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Atkinson, Victoria, Dutriaux, Caroline, Garbe, Claus, Hsu, Jessie, Jones, Surai, Li, Haocheng, McKenna, Edward, Voulgari, Athina, McArthur, Grant A.
Publicado 2021